Genetic polymorphisms of arsenic (+3 oxidation state) methyltransferase (AS3MT) influences arsenic metabolism -: Evidence from a population group in Argentina

被引：0
|
作者：
Schlawicke, Karin Maria [1 ]
Broberg, Karin [1 ]
Concha, Gabriela [1 ]
Nermell, Barbro [1 ]
Warholm, Margareta [1 ]
Vahter, Marie [1 ]
机构：
[1] Lund Univ, Lund, Sweden
来源：
TOXICOLOGY LETTERS | 2006年 / 164卷
关键词：
D O I：
10.1016/j.toxlet.2006.07.053
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
引用
收藏
页码：S190 / S191
页数：2
相关论文
共 50 条
  • [1] Polymorphisms in Arsenic( plus III Oxidation State) Methyltransferase (AS3MT) Predict Gene Expression of AS3MT as Well as Arsenic Metabolism
    Engstrom, Karin
    Vahter, Marie
    Mlakar, Simona Jurkovic
    Concha, Gabriela
    Nermell, Barbro
    Raqib, Rubhana
    Cardozo, Alejandro
    Broberg, Karin
    ENVIRONMENTAL HEALTH PERSPECTIVES, 2011, 119 (02) : 182 - 188
  • [2] Genetic Variation in Arsenic (+3 Oxidation State) Methyltransferase (AS3MT), Arsenic Metabolism and Risk of Basal Cell Carcinoma in a European Population
    Engstrom, Karin S.
    Vahter, Marie
    Fletcher, Tony
    Leonardi, Giovanni
    Goessler, Walter
    Gurzau, Eugen
    Koppova, Kvetoslava
    Rudnai, Peter
    Kumar, Rajiv
    Broberg, Karin
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2015, 56 (01) : 60 - 69
  • [3] Ethnic differences in five intronic polymorphisms associated with arsenic metabolism within human arsenic (+3 oxidation state) methyltransferase (AS3MT) gene
    Fujihara, Junko
    Fujii, Yoshimi
    Agusa, Tetsuro
    Kunito, Takashi
    Yasuda, Toshihiro
    Moritani, Tamami
    Takeshita, Haruo
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2009, 234 (01) : 41 - 46
  • [4] Global analysis of genetic variation in human arsenic (+3 oxidation state) methyltransferase (AS3MT)
    Fujihara, Junko
    Soejima, Mikiko
    Yasuda, Toshihiro
    Koda, Yoshiro
    Agusa, Tetsuro
    Kunito, Takashi
    Tongu, Miki
    Yamada, Takaya
    Takeshita, Haruo
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2010, 243 (03) : 292 - 299
  • [5] Polymorphisms in arsenic (+3 oxidation state) methyltransferase (AS3MT) predict the occurrence of hyperleukocytosis and arsenic metabolism in APL patients treated with As2O3
    Liu, Wen-Sheng
    Wang, Xin-Yu
    Lu, Jing
    Zhang, Ying-Mei
    Ye, Xiang-Mei
    Li, Jin-Mei
    Zhao, Qi-Lei
    Wu, Zhi-Qiang
    Zhou, Jin
    Hai, Xin
    ARCHIVES OF TOXICOLOGY, 2020, 94 (04) : 1203 - 1213
  • [6] Polymorphisms in arsenic (+ 3 oxidation state) methyltransferase (AS3MT) predict the occurrence of hyperleukocytosis and arsenic metabolism in APL patients treated with As2O3
    Wen-Sheng Liu
    Xin-Yu Wang
    Jing Lu
    Ying-Mei Zhang
    Xiang-Mei Ye
    Jin-Mei Li
    Qi-Lei Zhao
    Zhi-Qiang Wu
    Jin Zhou
    Xin Hai
    Archives of Toxicology, 2020, 94 : 1203 - 1213
  • [7] Effects of human AS3MT genetic polymorphisms on arsenic metabolism in Taiwanese
    Li, Wan-Fen
    Sun, Chien-Wen
    Liao, Ya-Tang
    Chen, Chien-Jen
    Wang, Shu-Li
    TOXICOLOGY LETTERS, 2009, 189 : S223 - S223
  • [8] Analysis of maternal polymorphisms in arsenic (+3 oxidation state)-methyltransferase AS3MT and fetal sex in relation to arsenic metabolism and infant birth outcomes: Implications for risk analysis
    Drobna, Zuzana
    Martin, Elizabeth
    Kim, Kyung Su
    Smeester, Lisa
    Bommarito, Paige
    Rubio-Andrade, Marisela
    Garcia-Vargas, Gonzalo G.
    Styblo, Miroslav
    Zou, Fei
    Fry, Rebecca C.
    REPRODUCTIVE TOXICOLOGY, 2016, 61 : 28 - 38
  • [9] Individual Variations in Inorganic Arsenic Metabolism Associated with AS3MT Genetic Polymorphisms
    Agusa, Tetsuro
    Fujihara, Junko
    Takeshita, Haruo
    Iwata, Hisato
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2011, 12 (04): : 2351 - 2382
  • [10] Genetic polymorphisms in AS3MT and arsenic metabolism in residents of the Red River Delta, Vietnam
    Agusa, Tetsuro
    Iwata, Hisato
    Fujihara, Junko
    Kunito, Takashi
    Takeshita, Haruo
    Minh, Tu Binh
    Trang, Pham Thi Kim
    Viet, Pham Hung
    Tanabe, Shinsuke
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2009, 236 (02) : 131 - 141
12345